ARTICLE | Company News
Argonex, Wyeth-Lederle Vaccines deal
February 7, 2000 8:00 AM UTC
Argonex will isolate, identify and sequence peptides expressed on Chlamydia pneumoniae-infected cells. Wyeth will evaluate the peptides for use in developing vaccines, and Argonex will receive resear...